Panobinostat was shown to inhibit tumor growth and metastasis by downregulating the Wnt/β-catenin signaling pathway through upregulating the expression of the adenomatous polyposis coli protein-like (APCL) tumor suppressor gene in breast cancer cells [148]. Here, APC2 is linked to breast carcinoma.